Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
120.50    -0.50 (-0.41%)
Bid:
120.50
Ask:
121.00
Spread: 0.50 (0.415%)
Market Cap: £278.97m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

COVID-19 Update

5 Nov 2020 07:00

RNS Number : 3083E
DFS Furniture PLC
05 November 2020
 

5 November 2020

 

DFS Furniture plc

 

COVID-19 Update

 

 

Manufacturing and deliveries continuing through current national lockdowns

Robust balance sheet; net cash position with access to over £300m of funds

Current lockdown measures not expected to materially impact profitability for the first half

 

DFS Furniture plc today issues an update in the light of increasing restrictions on the movement of people and trading activity being put in place by Governments to restrict the spread of COVID‐19 in many of the markets where the Group's brands trade.

 

Update on showrooms, manufacturing and delivery

As of today, the 5th November, following Government legislation all physical showrooms in England, the Republic of Ireland and Wales, are temporarily closed, which together represent 181 of our 208 showrooms across the estate. All showrooms in all other territories are open and trading.

 

Under current legislation, in England our showrooms (169) are closed for four weeks from 5 November to 2 December. Our Welsh showrooms (7) are due to re-open on Monday 9 November, following 16 days of closure. Our Irish showrooms (5) are due to reopen on 1 December, following six weeks of closure. 

 

Our websites across all brands and territories remain open for business and are performing well. Based on our previous experience of lockdown we expect our online business to improve further. This will be supported by the temporary transfer of showroom colleagues to other areas of the business, including remotely assisting customers with web purchases.

 

Notwithstanding the showroom restrictions, we continue to manufacture, deliver and install orders safely into customer homes in all territories. Given the current very strong order bank levels, and the delivery lead times we are therefore operating at, we do not expect that this period of showroom closure will materially impact revenues and profitability for the first 26 weeks to 27 December 2020.

 

Furthermore, our experience of the prior lockdown periods was that substantially all order intake disrupted during the lockdown period was either deferred until showrooms reopened or was captured online. 

 

Strong Financial Position

Our balance sheet position remains robust. With the strength of recent trading, helped by associated working capital inflows, we currently hold a net cash position, with access to over £300m of available cash and undrawn bank facilities.

 

Our next scheduled trading update is the 12 January 2021, covering trading performance over the 26 weeks to 27 December 2020.

 

 

Enquiries:

DFS (enquiries via Tulchan)

Tim Stacey (Group CEO)

Mike Schmidt (Group CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Tulchan

James Macey-White

Jessica Reid

Amber Ahluwalia

+44 (0)20 7353 4200

dfs@tulchangroup.com

 

About DFS Furniture plc

DFS is the clear market leading retailer of living room furniture in the United Kingdom. We design, manufacture, sell and deliver to our customers an extensive range of furniture products. The business operates a retail network of living room furniture stores in the United Kingdom and Europe, together with an online channel. These have been established and developed gradually over 50 years of operating history. We attract customers to our stores and websites through our substantial and continued investment in nationwide marketing activities and our reputation for high quality products and service, breadth of product ranges and price points and favourable consumer financing options.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKQBKCBDDODK
Date   Source Headline
20th May 20264:31 pmRNSHolding(s) in Company
6th May 20267:00 amRNSDirectorate change
30th Apr 20267:00 amRNSPurchase of shares by Employee Benefit Trust
1st Apr 20263:06 pmRNSEBT Update
19th Mar 20267:00 amRNSInterim Results
20th Jan 20267:00 amRNSTrading Statement
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSTotal Voting Rights
8th Dec 20251:40 pmRNSTotal Voting Rights
17th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20254:17 pmRNSDirectorate change
14th Nov 20253:47 pmRNSResult of AGM
14th Nov 20257:00 amRNSAGM Trading Statement
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20251:19 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSDirector/PDMR Shareholding
20th Oct 202510:35 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSAnnual Financial Report
25th Sep 20257:00 amRNSFY25 Preliminary Results
12th Aug 20258:00 amRNSDirector Declaration
17th Jul 20257:00 amRNSTrading Statement
13th May 202511:59 amRNSHolding(s) in Company
10th Apr 202512:46 pmRNSInvestor Presentation via Investor Meet Company
9th Apr 202511:29 amRNSDirectorate Change
4th Apr 202510:37 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Results
24th Feb 20257:00 amRNSDirectorate Change
12th Feb 20251:15 pmRNSChange of Adviser
7th Feb 20253:14 pmRNSHolding(s) in Company
5th Feb 20259:28 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSDirectorate Change
17th Jan 20257:00 amRNSTrading Statement
8th Jan 202512:05 pmRNSHolding(s) in Company
7th Jan 202512:34 pmRNSHolding(s) in Company
6th Jan 20252:47 pmRNSHolding(s) in Company
3rd Jan 20252:17 pmRNSHolding(s) in Company
13th Dec 20247:00 amRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSHolding(s) in Company
27th Nov 20247:00 amRNSValidation of SBTi Targets
25th Nov 202411:52 amRNSHolding(s) in Company
25th Nov 202410:57 amRNSHolding(s) in Company
22nd Nov 20243:31 pmRNSResult of AGM
22nd Nov 20247:00 amRNSTrading Update and Directorate Change
19th Nov 20249:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.